PT - JOURNAL ARTICLE AU - Nicastro, Fabrizio AU - Sironi, Giorgia AU - Antonello, Elio AU - Bianco, Andrea AU - Biasin, Mara AU - Brucato, John R. AU - Ermolli, Ilaria AU - Pareschi, Giovanni AU - Salvati, Marta AU - Tozzi, Paolo AU - Trabattoni, Daria AU - Clerici, Mario TI - Modulation of COVID-19 Epidemiology by UV-B and –A Photons from the Sun AID - 10.1101/2020.06.03.20121392 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.03.20121392 4099 - http://medrxiv.org/content/early/2020/07/28/2020.06.03.20121392.short 4100 - http://medrxiv.org/content/early/2020/07/28/2020.06.03.20121392.full AB - Solar UV-C photons do not reach Earth’s surface, but are known to be endowed with germicidal properties that are also effective on viruses. The effect of softer UV-B/A photons, which reach the Earth’s surface, on viruses are instead little studied.Here we show that the evolution and strength of the recent SARS-Cov-2 pandemics, might have been modulated by the intensity of UV-B/A Solar radiation hitting different regions of Earth during the diffusion of the outbreak. Our results suggest that Solar UV-B/A may play an important role in planning new strategies of confinement of the epidemics.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Milano INAFAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFor the UV illumination data we used public data provided by the TEMIS network http://www.temis.nl/ SARS-CoV-2 data are taken by the GitHub repository provided by the Coronavirus Resource Center of the John Hopkins University: https://github.com/CSSEGISandData/COVID-19